CD274 and colitis: Compared with the untreated colitis group, the PD-L1-Fc-treated, PD-L1-Fc/PLGA nanoparticles-treated and PD-L1-Fc/Oxi-αCD nanoparticles-treated groups showed less weight loss, lower disease activity index (DAI) scores and longer colon lengths.